JP2015536939A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015536939A5 JP2015536939A5 JP2015540176A JP2015540176A JP2015536939A5 JP 2015536939 A5 JP2015536939 A5 JP 2015536939A5 JP 2015540176 A JP2015540176 A JP 2015540176A JP 2015540176 A JP2015540176 A JP 2015540176A JP 2015536939 A5 JP2015536939 A5 JP 2015536939A5
- Authority
- JP
- Japan
- Prior art keywords
- silica material
- porous silica
- material according
- food
- range
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 32
- 239000000463 material Substances 0.000 claims 16
- 239000000377 silicon dioxide Substances 0.000 claims 16
- 239000011148 porous material Substances 0.000 claims 11
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 8
- 239000000203 mixture Substances 0.000 claims 8
- 238000002560 therapeutic procedure Methods 0.000 claims 7
- 230000002265 prevention Effects 0.000 claims 5
- 210000000577 adipose tissue Anatomy 0.000 claims 4
- 239000008280 blood Substances 0.000 claims 4
- 210000004369 blood Anatomy 0.000 claims 4
- AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 claims 4
- 229960001243 orlistat Drugs 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 208000032928 Dyslipidaemia Diseases 0.000 claims 3
- 206010020772 Hypertension Diseases 0.000 claims 3
- 208000017170 Lipid metabolism disease Diseases 0.000 claims 3
- 208000008589 Obesity Diseases 0.000 claims 3
- 235000020824 obesity Nutrition 0.000 claims 3
- 239000000825 pharmaceutical preparation Substances 0.000 claims 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 2
- 235000012041 food component Nutrition 0.000 claims 2
- 239000005417 food ingredient Substances 0.000 claims 2
- 150000003626 triacylglycerols Chemical class 0.000 claims 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims 2
- 230000004580 weight loss Effects 0.000 claims 2
- 239000008186 active pharmaceutical agent Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000000796 flavoring agent Substances 0.000 claims 1
- 235000013355 food flavoring agent Nutrition 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 230000000069 prophylactic effect Effects 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 238000001179 sorption measurement Methods 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261723019P | 2012-11-06 | 2012-11-06 | |
| US61/723,019 | 2012-11-06 | ||
| PCT/EP2013/073200 WO2014072363A1 (en) | 2012-11-06 | 2013-11-06 | A porous silica material for use as a pharmaceutical or dietary active ingredient |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018194145A Division JP6752858B2 (ja) | 2012-11-06 | 2018-10-15 | 医薬有効成分又は食品有効成分としての使用のための多孔質シリカ材料 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015536939A JP2015536939A (ja) | 2015-12-24 |
| JP2015536939A5 true JP2015536939A5 (enExample) | 2016-12-22 |
| JP6421124B2 JP6421124B2 (ja) | 2018-11-07 |
Family
ID=49639855
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015540176A Active JP6421124B2 (ja) | 2012-11-06 | 2013-11-06 | 医薬有効成分又は食品有効成分としての使用のための多孔質シリカ材料 |
| JP2018194145A Active JP6752858B2 (ja) | 2012-11-06 | 2018-10-15 | 医薬有効成分又は食品有効成分としての使用のための多孔質シリカ材料 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018194145A Active JP6752858B2 (ja) | 2012-11-06 | 2018-10-15 | 医薬有効成分又は食品有効成分としての使用のための多孔質シリカ材料 |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US10695294B2 (enExample) |
| EP (2) | EP3892285A3 (enExample) |
| JP (2) | JP6421124B2 (enExample) |
| CN (2) | CN113069467A (enExample) |
| AU (1) | AU2013343565B2 (enExample) |
| BR (1) | BR112015010118A2 (enExample) |
| CA (3) | CA2890171C (enExample) |
| CY (1) | CY1124471T1 (enExample) |
| DK (1) | DK2916852T3 (enExample) |
| ES (1) | ES2878017T3 (enExample) |
| HR (1) | HRP20211036T1 (enExample) |
| HU (1) | HUE055017T2 (enExample) |
| IL (1) | IL238538B (enExample) |
| LT (1) | LT2916852T (enExample) |
| PH (1) | PH12015501010B1 (enExample) |
| PL (1) | PL2916852T3 (enExample) |
| PT (1) | PT2916852T (enExample) |
| SI (1) | SI2916852T1 (enExample) |
| WO (1) | WO2014072363A1 (enExample) |
| ZA (1) | ZA201502979B (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE055017T2 (hu) | 2012-11-06 | 2021-10-28 | Sigrid Therapeutics Ab | Pórusos szilíciumdioxid-anyag gyógyászati hatóanyagként vagy élelmiszerekben való alkalmazásra |
| NZ709368A (en) | 2012-12-21 | 2020-01-31 | National Health Res Inst | Mesoporous silica nanoparticles for oil absorption |
| US20200129444A1 (en) * | 2017-07-13 | 2020-04-30 | Carnegie Mellon University | Method of Increasing Epithelial Permeability Using Nanoparticles |
| EP3723721B1 (en) * | 2017-12-13 | 2021-09-15 | L.I.Co.Rice S.R.L. | Complex of lactoferrin and silica, process for preparing and compositions for oral hygiene |
| GB201803363D0 (en) | 2018-03-01 | 2018-04-18 | Sigrid Therapeutics Ab | New materials and uses thereof |
| PL3894857T3 (pl) * | 2019-04-15 | 2023-01-09 | Nanologica Ab | Puste porowate cząstki do stosowania w leczeniu, zapobieganiu i/lub opóźnianiu degeneracyjności chorób neurodgeneracyjnych, neuronów i gleju |
| CN110314151B (zh) * | 2019-08-02 | 2020-06-02 | 深圳国佳产业基金管理有限公司 | 医用介孔二氧化硅材料及其应用 |
| CN114729263A (zh) * | 2019-09-30 | 2022-07-08 | 零点火技术股份有限公司 | 隔热阻燃材料及其制造方法 |
| JP7578945B2 (ja) * | 2020-10-27 | 2024-11-07 | 信越化学工業株式会社 | イミダゾールシラン処理シリカからなる胆汁酸吸着剤 |
| CN114195885B (zh) * | 2022-01-12 | 2024-04-26 | 杭州隆基生物技术有限公司 | 一种单克隆抗体组合物提纯方法 |
| WO2023148307A1 (en) | 2022-02-04 | 2023-08-10 | Sigrid Therapeutics Ab | Oral care composition comprising porous silica particles |
| JP2025119063A (ja) | 2022-04-28 | 2025-08-14 | 日本たばこ産業株式会社 | 無機多孔質材料を含む口腔用組成物 |
| GB202212240D0 (en) | 2022-08-23 | 2022-10-05 | Sigrid Therapeutics Ab | New formulations and medical uses thereof |
| GB202212239D0 (en) | 2022-08-23 | 2022-10-05 | Sigrid Therapeutics Ab | New dietary supplements |
| CN116747321B (zh) * | 2023-06-14 | 2025-09-05 | 厦门君德医药科技有限公司 | 一种接枝改性的介孔二氧化硅及其制备方法和应用 |
| GB202312179D0 (en) | 2023-08-09 | 2023-09-20 | Sigrid Therapeutics Ab | New compositions and uses |
| GB202312176D0 (en) | 2023-08-09 | 2023-09-20 | Sigrid Therapeutics Ab | New uses and methods |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4185088A (en) | 1977-02-17 | 1980-01-22 | Merck & Co., Inc. | Non-adhesive ionene quaternary polymer compositions useful as bile acid sequestrants |
| US4180566A (en) * | 1978-05-15 | 1979-12-25 | W. R. Grace & Co. | Silica gel method of reducing blood lipid concentration |
| US4824672A (en) * | 1986-06-06 | 1989-04-25 | Hauser-Kuhrts, Inc. | Method and composition for reducing serum cholesterol |
| US5401466A (en) * | 1993-06-01 | 1995-03-28 | Miles Inc. | Device for the direct measurement of low density lipoprotein cholesterol |
| EP0778027A3 (de) | 1995-12-04 | 1998-04-01 | Helmut Univ.-Prof. Dr. Wachter | Verwendung von Kieselerde zur Herstellung von Arzneimitteln |
| EP0911078A1 (en) * | 1997-10-20 | 1999-04-28 | Hitachi Metals, Ltd. | Photocatalyst-supporting body and photocatalytic apparatus |
| ID27415A (id) * | 1998-06-30 | 2001-04-05 | Takeda Chemical Industries Ltd | Komposisi farmaseutik |
| AU7881000A (en) * | 1999-08-16 | 2001-03-13 | Henceforth Hibernia, Inc. | Therapeutic and prophylactic compositions including catalytic biomimetic solids and methods to prepare and use them |
| DE60106623T2 (de) | 2000-07-28 | 2006-02-02 | F. Hoffmann-La Roche Ag | Neue pharmazeutische zusammensetzung |
| US7074440B2 (en) * | 2002-05-01 | 2006-07-11 | Rulin Xiu | Compositions and methods for body weight loss |
| JP2004345895A (ja) * | 2003-05-21 | 2004-12-09 | Ajinomoto Co Inc | メソポーラスシリカ及びその製造方法 |
| JP2005289853A (ja) * | 2004-03-31 | 2005-10-20 | Ajinomoto Co Inc | 経口リン酸吸着剤 |
| GB0515353D0 (en) * | 2005-07-27 | 2005-08-31 | Psimedica Ltd | Food |
| KR100857411B1 (ko) | 2006-07-21 | 2008-09-08 | 한올제약주식회사 | 리파아제 저해제의 경구 투여용 방출조절 약학 제제 및이의 제조 방법 |
| BRPI0905910A2 (pt) | 2008-02-11 | 2015-06-23 | Alfonso Garcia-Bennett | Método para fabricar materiais mesoporosos, materiais assim produzidos e uso de materiais mesoporosos. |
| TW200936130A (en) * | 2008-02-26 | 2009-09-01 | Lundbeck & Co As H | Uses of indane compounds |
| US20110212055A1 (en) * | 2008-03-25 | 2011-09-01 | Commissiong John W | Neurodegenerative disorders |
| JP2010065023A (ja) * | 2008-08-14 | 2010-03-25 | Lion Corp | 脂溶性ビタミンおよび／または脂溶性色素含有粉体 |
| JP2012506904A (ja) | 2008-10-28 | 2012-03-22 | エージェンシー フォー サイエンス，テクノロジー アンド リサーチ | 難水溶性成分のためのメソ多孔性材料賦形剤 |
| DE102009026686A1 (de) * | 2009-06-03 | 2010-12-23 | Airbus France | Anordnung zum Blitzschutz einer elektronischen Einheit |
| EP2547733A1 (en) | 2010-03-17 | 2013-01-23 | Nanologica AB | Enhanced folic acid fluorescent material, multifluorescent porous compositions of matter and potential applications thereof |
| ES2768229T3 (es) * | 2010-07-06 | 2020-06-22 | Nanologica Ab | Método mejorado para diferenciación de células madre in vivo mediante la administración de morfógenos con sílice mesoporosa y principios activos farmacéuticos correspondientes |
| GB201212866D0 (en) | 2012-07-20 | 2012-09-05 | Formac Pharmaceuticals Nv | Dry granulates of mesoporous silica powders |
| HUE055017T2 (hu) | 2012-11-06 | 2021-10-28 | Sigrid Therapeutics Ab | Pórusos szilíciumdioxid-anyag gyógyászati hatóanyagként vagy élelmiszerekben való alkalmazásra |
| PL2919903T3 (pl) | 2012-11-14 | 2020-12-14 | W.R. Grace & Co. - Conn. | Kompozycje zawierające materiał biologicznie aktywny i nieuporządkowany tlenek nieorganiczny |
| NZ709368A (en) | 2012-12-21 | 2020-01-31 | National Health Res Inst | Mesoporous silica nanoparticles for oil absorption |
-
2013
- 2013-11-06 HU HUE13795191A patent/HUE055017T2/hu unknown
- 2013-11-06 WO PCT/EP2013/073200 patent/WO2014072363A1/en not_active Ceased
- 2013-11-06 PH PH1/2015/501010A patent/PH12015501010B1/en unknown
- 2013-11-06 SI SI201331885T patent/SI2916852T1/sl unknown
- 2013-11-06 HR HRP20211036TT patent/HRP20211036T1/hr unknown
- 2013-11-06 AU AU2013343565A patent/AU2013343565B2/en active Active
- 2013-11-06 DK DK13795191.9T patent/DK2916852T3/da active
- 2013-11-06 BR BR112015010118A patent/BR112015010118A2/pt not_active Application Discontinuation
- 2013-11-06 LT LTEP13795191.9T patent/LT2916852T/lt unknown
- 2013-11-06 CN CN202110214365.4A patent/CN113069467A/zh active Pending
- 2013-11-06 EP EP21162691.6A patent/EP3892285A3/en not_active Withdrawn
- 2013-11-06 CN CN201380069421.3A patent/CN105188720A/zh active Pending
- 2013-11-06 JP JP2015540176A patent/JP6421124B2/ja active Active
- 2013-11-06 CA CA2890171A patent/CA2890171C/en active Active
- 2013-11-06 EP EP13795191.9A patent/EP2916852B1/en active Active
- 2013-11-06 US US14/440,784 patent/US10695294B2/en active Active
- 2013-11-06 PT PT137951919T patent/PT2916852T/pt unknown
- 2013-11-06 CA CA3024640A patent/CA3024640A1/en not_active Abandoned
- 2013-11-06 ES ES13795191T patent/ES2878017T3/es active Active
- 2013-11-06 PL PL13795191T patent/PL2916852T3/pl unknown
-
2015
- 2015-04-30 ZA ZA2015/02979A patent/ZA201502979B/en unknown
- 2015-04-30 IL IL238538A patent/IL238538B/en active IP Right Grant
-
2018
- 2018-10-15 JP JP2018194145A patent/JP6752858B2/ja active Active
- 2018-11-15 CA CA3024460A patent/CA3024460A1/fr active Pending
-
2020
- 2020-06-26 US US16/913,533 patent/US12121612B2/en active Active
-
2021
- 2021-07-13 CY CY20211100628T patent/CY1124471T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015536939A5 (enExample) | ||
| HRP20211036T1 (hr) | Porozni materijal silicij-dioksida za upotrebu kao farmaceutski ili dijetetski aktivni sastojak | |
| DK1632252T3 (da) | Hæmostatiske sammensætninger og anordninger | |
| JP2010104979A5 (enExample) | ||
| JP2013516442A5 (enExample) | ||
| PT2210588E (pt) | Composição expansível, essencialmente isenta de ingredientes farmaceuticamente activos para o tratamento da pele humana | |
| JP2015515475A5 (enExample) | ||
| TN2012000566A1 (en) | Dry powder formulation comprising an antimuscarinic drug | |
| SG11201804449WA (en) | 2-phenyl-3-(piperazinomethyl)imidazo[1,2-a]pyridine derivatives as blockers of task-1 and task-2 channels, for the treatment of sleep-related breathing disorders | |
| IL183360A (en) | 12-aryl prostaglandin analogs, compositions comprising them and their use in the preparation of medicaments | |
| JP2015525099A5 (enExample) | ||
| HK1198279A1 (en) | Treatment of multiple sclerosis with combination of laquinimod and glatiramer acetate | |
| HK1198278A1 (en) | Treatment of multiple sclerosis with combination of laquinimod and interferon-beta | |
| GB201204696D0 (en) | Therapy | |
| WO2012098562A3 (en) | Liquid oral compositions of lanthanum salts | |
| JP2014510590A5 (enExample) | ||
| CN104146555B (zh) | 一种中药药枕 | |
| WO2011101734A3 (en) | Taste-masked powder for suspension compositions of methylprednisolone | |
| WO2011093815A3 (en) | Pharmaceutical compositions comprising formoterol and mometasone | |
| WO2011093818A3 (en) | Pharmaceutical compositions comprising salmeterol and fluticasone | |
| JP2014500257A5 (enExample) | ||
| WO2016025671A3 (en) | Treatment of sleep apnea with a combination of a carbonic anhydrase inhibitor and an aldosterone antagonist | |
| JP2016523943A5 (enExample) | ||
| HRP20221034T1 (hr) | Aklidinij za upotrebu u povećanju fizičke aktivnosti u dnevnom životu kod pacijenta koji pati od kronične opstruktivne bolesti pluća | |
| WO2011093811A3 (en) | Pharmaceutical preparations comprising formoterol and fluticasone |